EC
COLL icon

EcoR1 Capital’s Collegium Pharmaceutical COLL Stock Holding History

EcoR1 Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-281,776
Closed -$3.34M – 33
2016
Q2 		$3.34M Sell
281,776
-191,347
-40% -$3.16M 1.32% 21
2016
Q1 		$8.59M Buy
473,123
+8,005
+2% +$146K 3% 14
2015
Q4 		$12.8M Hold
465,118
– – 4.02% 10
2015
Q3 		$10.3M Hold
465,118
– – 4.68% 9
2015
Q2 		$8.3M Buy
+465,118
New +$8.04M 2.77% 11

Other funds holding COLL

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital's COLL Position: Q3 2016 in Review

EcoR1 Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2016, closing a stake of 281,776 shares — an estimated $3.34M sold.

EcoR1 Capital first reported a position in COLL in Q2 2015 and held it in 5 quarters. The position peaked at $12.8M in Q4 2015. 72 funds tracked by Wall St. Rank hold COLL as of Q3 2016.

  • EcoR1 Capital reported no remaining Collegium Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • EcoR1 Capital sold 281,776 Collegium Pharmaceutical shares in Q3 2016, an estimated $3.34M.
  • EcoR1 Capital first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 5 quarters.
  • EcoR1 Capital's Collegium Pharmaceutical position peaked at $12.8M in Q4 2015.
  • 72 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2016.

Based on EcoR1 Capital's 13F filing for Q3 2016, filed 14 Nov 2016.